Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422422
Status:
COMPLETED
Last Update Posted:
2018-07-11
First Post:
2007-01-10
Brief Title:
Open-label Pharmacokinetic Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
N01263
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None